Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.

Jent, P.; Trippel, M.; Frey, M.; Pöllinger, A.; Berezowska, S.; Langer, R.; Furrer, H.; Béguelin, C.

doi:10.1093/ofid/ofy244

Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.

Details

Request a copy

Serval ID

serval:BIB_4DA875C8C3D4

Type

Article: article from journal or magazin.

Publication sub-type

Case report (case report): feedback on an observation with a short commentary.

Collection

Publications

Institution

Production externe

Title

Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient.

Journal

Open forum infectious diseases

Author(s)

Jent P., Trippel M., Frey M., Pöllinger A., Berezowska S., Langer R., Furrer H., Béguelin C.

ISSN

2328-8957 (Print)

ISSN-L

2328-8957

Publication state

Published

Issued date

11/2018

Peer-reviewed

Oui

Volume

Number

Pages

ofy244

Language

english

Notes

Publication types: Journal Article
Publication Status: epublish

Abstract

We report the case of a young patient treated with rituximab-containing chemotherapy who was infected with measles despite previous vaccination. Treatment with vitamin A, ribavirin, and immunoglobulins was started; nevertheless he developed severe pneumonitis and deceased. Broad vaccination coverage is crucial in protecting vulnerable subjects.

Keywords

immunocompromised, measles, rituximab, vaccination

DOI

10.1093/ofid/ofy244

Pubmed

30397623

Web of science

000457594300006

Open Access

Yes

Create date

29/06/2020 12:43